Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee

  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home Markt vandaag Koersen Forum Premium IEX Expert
Home  /  Forum  /  Crucell  /  Where the Hell is the News?

Crucell« Terug naar discussie overzicht

Where the Hell is the News?

Volgen
129 Posts
Pagina: «« 1 2 3 4 5 6 7 »» | Laatste | Omlaag ↓
  3. [verwijderd] 15 april 2009 21:21
    quote:

    aossa schreef:

    [quote=ron banged]Things are so slow that no one has even bothered to start a April 15th thread.[/quote]
    The kids are playing elsewhere ...
    I like the lower decibels !
    The kids are playing somewhere else, and the Big Boys have taken their ball and gone home.

    You may like the lower decibels, but I don't like the lower PPS, especially as it is about to break support.
  4. [verwijderd] 15 april 2009 22:46
    As I see it the PPS is now staying in line with general market movements.

    As long as no company news is sent out, this is to be expected.

    Though I prefer a slow steady climb I get the impression that relatively small news may not be published not only because it is small in effect on 2009 predicted turnover, but also because some big news is on its way dwarfing any press release they could send out now but are apparently saved up for 6 May.

    We will see soon what is happening.
  5. [verwijderd] 16 april 2009 13:06
    quote:

    grapesharvester schreef:

    As I see it the PPS is now staying in line with general market movements.

    (no, crucell has consistently been 1% below market for the past month...that is why over the course of the last month, the market is up 20% and crucell is down)

    As long as no company news is sent out, this is to be expected.

    (my point exactly)

    Though I prefer a slow steady climb I get the impression that relatively small news may not be published not only because it is small in effect on 2009 predicted turnover, but also because some big news is on its way dwarfing any press release they could send out now but are apparently saved up for 6 May.

    (I don't want small news either...I want some TB study results or Flavimun launched, or Epaxal Jr push to into the US...instead of sound of Brus' snoring)

    We will see soon what is happening.

    (Another 3 weeks? Again, last time the company went on a news black-out the stock eventually plummeted to a 52 week low)

    Here is a chart showing the S+P up 13% over the past month, and Crucell down 7% over the past month

    stockcharts.com/h-sc/ui?s=CRXL&p=D&yr...
  6. z0n0p 16 april 2009 13:08
    quote:

    ron banged schreef:

    [quote=grapesharvester]
    As I see it the PPS is now staying in line with general market movements.

    (no, crucell has consistently been 1% below market for the past month...that is why over the course of the last month, the market is up 20% and crucell is down)

    As long as no company news is sent out, this is to be expected.

    (my point exactly)

    Though I prefer a slow steady climb I get the impression that relatively small news may not be published not only because it is small in effect on 2009 predicted turnover, but also because some big news is on its way dwarfing any press release they could send out now but are apparently saved up for 6 May.

    (I don't want small news either...I want some TB study results or Flavimun launched, or Epaxal Jr push to into the US...instead of sound of Brus' snoring)

    We will see soon what is happening.

    (Another 3 weeks? Again, last time the company went on a news black-out the stock eventually plummeted to a 52 week low)

    Here is a chart showing the S+P up 13% over the past month, and Crucell down 7% over the past month

    stockcharts.com/h-sc/ui?s=CRXL&p=D&yr...
    [/quote]
    BORING!
  7. [verwijderd] 16 april 2009 13:18

    [/quote]

    BORING!
    [/quote]
    Stock down another 5% today, with The AEX up,

    YEP,,,,boring and depressing
    Flucell, and Sanofi buying everything else that isn't tied down...the assumption is Sanofi is not interested in Crucell...hence one of the potential(and most logical) buyers is off the market.
  8. z0n0p 16 april 2009 13:21
    quote:

    ron banged schreef:

    [/quote]

    BORING!
    [/quote]
    Stock down another 5% today, with The AEX up,

    YEP,,,,boring and depressing
    Flucell, and Sanofi buying everything else that isn't tied down...the assumption is Sanofi is not interested in Crucell...hence one of the potential(and most logical) buyers is off the market.
    1 maart 2004:

    AEX: 361; Crucell: € 5,91.
  9. [verwijderd] 16 april 2009 13:27
    quote:

    z0n0p schreef:

    [quote=ron banged]

    [/quote]

    BORING!
    [/quote]
    Stock down another 5% today, with The AEX up,

    YEP,,,,boring and depressing
    Flucell, and Sanofi buying everything else that isn't tied down...the assumption is Sanofi is not interested in Crucell...hence one of the potential(and most logical) buyers is off the market.
    [/quote]

    1 maart 2004:

    AEX: 361; Crucell: € 5,91.

    Drag out the 2004 prices...Might as well drag out the 1933 Dow Jones prices to show how well the US market is doing.

    Crucell and Brus have gone into shutdown...I don't know why...and haven't delivered on their promises they made(Keep our Promises!) in the Feb CC, hence the destruction of the PPS in the face of a 20% run in the averages. I'm sorry, but when the market is up 20% over the month and a stock is down 10$ in the face of it...that is not good or boring.
  10. z0n0p 16 april 2009 13:40
    quote:

    ron banged schreef:

    [quote=z0n0p]
    [quote=ron banged]

    [/quote]

    BORING!
    [/quote]
    Stock down another 5% today, with The AEX up,

    YEP,,,,boring and depressing
    Flucell, and Sanofi buying everything else that isn't tied down...the assumption is Sanofi is not interested in Crucell...hence one of the potential(and most logical) buyers is off the market.
    [/quote]

    1 maart 2004:

    AEX: 361; Crucell: € 5,91.

    [/quote]
    Drag out the 2004 prices...Might as well drag out the 1933 Dow Jones prices to show how well the US market is doing.

    Crucell and Brus have gone into shutdown...I don't know why...and haven't delivered on their promises they made(Keep our Promises!) in the Feb CC, hence the destruction of the PPS in the face of a 20% run in the averages. I'm sorry, but when the market is up 20% over the month and a stock is down 10$ in the face of it...that is not good or boring.
    AEX is down almost 4% in 2009, Crucell at this moment 31% UP. And you talk about time perspective????????????
  15. [verwijderd] 18 april 2009 12:07
    Van GoCrucellGo 17.04.2009 NEWS/RESEARCH
    www.uib.no/gades/en/nyheter/2009/04/c...
    Clinical trial of an avian influenza vaccine
    The Influenza Centre at the Gade Institute, University of Bergen, has, in cooperation with European researchers, developed a new vaccine against the bird flu. This vaccine will now be tested at the Haukeland University Hospital.
    By Kristian Jensen
    Since 2003, 417 people, mainly in South East Asia, have been infected with the bird flu, H5N1. 257 of these died. Should the virus mutate, and become more transmissible between people, a so-called pandemic (a worldwide outbreak affecting a large number of people) might occur. The virus could, in such an event, spread quickly all over the world and cause an unusual amount of serious illness and high mortality. Recent pandemics include the 1918 Spanish Flu, the 1957 Asian flu, and the 1968 Hong Kong Flu. All of these pandemics have their origin in bird flu strains. Many experts and health agencies are currently concerned that the H5N1-virus which has arisen in recent years may evolve into such a pandemic virus.
    This study aims to test a novel vaccine previously not tested on humans. Bird flu vaccines tested in human clinical trials to date have been well tolerated by humans. The study is financed by the EU-project PANFLUVAC, Helse Vest and the University of Bergen, and is approved by SLV and REK. Collaborative partners from several European nations (Great Britain, Italy, Switzerland, Germany, The Netherlands, Norway) are involved in the project, and the vaccine is produced by the vaccine producer Crucell Berna Biotech Ltd under contract from the EU PANFLUVAC project.
    The Influenza Centre aims to recruit 60 healthy individuals aged 19-50 in order to study the immune response elicited by this bird flu vaccine, as well as register any side effects. The vaccine will be tested in three different degrees of strength together with a new strength enhancer (adjuvant) and as vaccine without strength enhancer. It is expected that the participants in this clinical trial will be better protected than those who are not administered such a test vaccine. The study will yield important information for development and efficacy of a new bird flu vaccine, as well as provide information as to how long the vaccine confers protection. This information will be very valuable in the event of a new pandemic.

  16. [verwijderd] 18 april 2009 16:14
    Het news van februari dit jaar: jaarlijkse omzetgroei van 20% (conservative).

    In de attach het effect daarvan op de jaarwinst. Dus uitsluitend op basis van autonome omzetgroei en dus beperkt invloed van extras, zoals Wyeth-deal, proteins, flu, milestones, etc.

    Niet genoeg? Dan maandag traden met financials!
    Bijlage:
  18. [verwijderd] 18 april 2009 18:01
    En dit is nog conservatief, immers de winst zal veel sneller stijgen dan de omzet door "the economy of scale". Ik verwacht zo'n 100 miljoen dollar in 2009.
    Key factor in 2009 zullen de nieuwe vaccin tenders zijn en of het lukt, zoals Flosz al aangestipt heeft, om polio toe te voegen. Ik blijf erg positief en uiteraard long in Crucell, wel alleen aandelen vanwege datgene wat we deze week weer hebben mogen ervaren.
  19. [verwijderd] 18 april 2009 20:02
    quote:

    callhans schreef:

    En dit is nog conservatief, immers de winst zal veel sneller stijgen dan de omzet door "the economy of scale". Ik verwacht zo'n 100 miljoen dollar in 2009.
    Key factor in 2009 zullen de nieuwe vaccin tenders zijn en of het lukt, zoals Flosz al aangestipt heeft, om polio toe te voegen. Ik blijf erg positief en uiteraard long in Crucell, wel alleen aandelen vanwege datgene wat we deze week weer hebben mogen ervaren.
    Yes at one point Brus hinted at hexavalent vaccine, hell he threw in a heptavalent and an octavalent as well...but that was when he was riffing during a Q+A, which means it is a totally worthless statement. I don't know where he gets half the shit he talks about during Q+A, since nothing comes of it...hell, half the stuff during the actual presentation falls off the edge of the earth never to be heard from again.

    I could run through the usual suspects...the most onerous being the Factor V POC blatant lie, but even just recently(last June)...the talk of getting Epaxal Jr into the US market...how it is superior in every respect, and how the US market's margins are so much higher...only to have it languish and die.

    I was promised at the last CC news on Flavimun and TB....C'mon Ronald...keep your promises. I sure if Ronald talked about throwing another party in Switzerland during a CC, he would keep that promise. Especially on the shareholders dime.
  20. [verwijderd] 18 april 2009 20:26
    bijna de hele omzet van Cru is Quinvaxim,verkregen door de overname van Berna.

    wat presteren ze zelf?
    een pipeline waar nog steeds niks uitgekomen is wat een beetje omzet genereert.

    een koers van 8 euro is nog teveel betaald.

    6 mei zullen we wel weer horen dat er weer wat uitstel en afstel is.

    Petercam zit al klaar.

129 Posts
Pagina: «« 1 2 3 4 5 6 7 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
Sligro 12,460 +0,16 +1,30%
Fugro 23,600 +0,30 +1,29%
NSI 19,900 +0,22 +1,12%
Nedap N.V. 63,600 +0,60 +0,95%
UMG 27,650 +0,25 +0,91%
BESI 170,000 +1,35 +0,80%
Basic-Fit 22,320 +0,14 +0,63%
Sif Holding 12,800 +0,08 +0,63%
Wereldhave 13,660 +0,08 +0,59%
KPN 3,661 +0,02 +0,58%
ALLFUNDS GROUP 5,320 +0,03 +0,47%
ArcelorMittal 21,660 +0,09 +0,42%
HEIJMANS KON 24,450 +0,10 +0,41%
BAM 4,392 +0,01 +0,32%
NN Group 45,000 +0,13 +0,29%
ASR Nederland 45,980 +0,11 +0,24%
ASMI 740,200 +1,60 +0,22%
Eurocommercial Properties 23,150 +0,05 +0,22%
Avantium 2,545 +0,00 +0,20%
SBM Offshore 14,320 +0,02 +0,14%
AALBERTS NV 40,320 0,00 0,00%
Accsys 0,652 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
TomTom 5,100 -0,47 -8,36%
EBUSCO HOLDING 1,432 -0,08 -5,17%
AZERION 1,594 -0,04 -2,69%
Philips Koninklijke 23,980 -0,63 -2,56%
DSM FIRMENICH AG 108,000 -2,75 -2,48%
INPOST 16,050 -0,39 -2,37%
Galapagos 24,460 -0,56 -2,24%
PROSUS 33,640 -0,73 -2,11%
Aegon 5,824 -0,10 -1,69%
AMG Critical Materials N.V. 16,120 -0,27 -1,65%
ADYEN NV 1.139,400 -18,60 -1,61%
Vastned 24,550 -0,40 -1,60%
RENEWI 8,130 -0,13 -1,57%
Kendrion 12,600 -0,20 -1,56%
B&S Group SA 4,810 -0,08 -1,54%
Van Lanschot Kempen NV 39,300 -0,60 -1,50%
Pharming 0,787 -0,01 -1,32%
FASTNED 16,620 -0,22 -1,31%
ASML 989,200 -13,00 -1,30%
JUST EAT TAKEAWAY 11,405 -0,15 -1,26%
Akzo Nobel 57,560 -0,68 -1,17%
OCI 23,400 -0,27 -1,14%
CTP 16,420 -0,18 -1,08%
WDP 26,480 -0,28 -1,05%
EXOR NV 97,850 -0,90 -0,91%
RELX 42,240 -0,38 -0,89%
Arcadis 61,850 -0,55 -0,88%
Ahold Delhaize 28,570 -0,25 -0,87%
IMCD 130,850 -1,10 -0,83%
CM.COM 7,150 -0,06 -0,83%
ING 16,638 -0,13 -0,80%
AEX 937,47 -7,44 -0,79%
Brunel 10,500 -0,08 -0,76%
Vopak 40,260 -0,28 -0,69%
ACOMO 17,680 -0,12 -0,67%
NX FILTRATION 6,000 -0,04 -0,66%
Heineken 88,760 -0,58 -0,65%
UNILEVER PLC 52,440 -0,34 -0,64%
AMX 889,61 -5,68 -0,63%
THEON INTERNAT 12,800 -0,08 -0,62%
ASCX 1.269,51 -7,90 -0,62%
Corbion 19,670 -0,12 -0,61%
JDE PEET'S 18,400 -0,10 -0,54%
Aperam 25,800 -0,14 -0,54%
SIGNIFY NV 24,800 -0,12 -0,48%
Fagron 18,460 -0,08 -0,43%
Wolters Kluwer 153,250 -0,60 -0,39%
ForFarmers 2,960 -0,01 -0,34%
PostNL 1,260 0,00 -0,32%
Flow Traders 18,740 -0,05 -0,27%
RANDSTAD NV 44,660 -0,09 -0,20%
Air France-KLM 8,030 -0,02 -0,20%
SHELL PLC 33,485 -0,06 -0,19%
Alfen N.V. 18,475 -0,03 -0,16%
ABN AMRO BANK N.V. 15,885 -0,02 -0,13%
TKH 43,440 -0,04 -0,09%
NEEM NU EEN ABONNEMENT OP IEX PREMIUM > NU 3 MAANDEN VOOR SLECHTS €24,95!
vlag naam koers verschil relatief verschil
AEX 937,47 -7,44 -0,79%
AEX GR 3.637,10 -28,85 -0,79%
Germany40^ 18.568,50 -22,39 -0,12%
FTSE 100 8.182,96 -69,95 -0,85%
EURO50 4.969,85 0,00 0,00%
US30^ 40.242,20 0,00 0,00%
Nasd100^ 20.393,80 0,00 0,00%
US500^ 5.633,38 0,00 0,00%
Japan225^ 41.113,60 0,00 0,00%
VD-NEW 12,93 +0,47 +3,78%
#/^ Index indications calculated real time, zie disclaimer